Press Releases ReNeuron Group plc

Equities

Delayed London S.E. Other stock markets 09:30:01 2024-02-05 am EST			5-day change	1st Jan Change
3.375 ^GBX	-2.17%		-.--%	-3.57%

Apr. 17	ReNeuron Group Reports CFO Resignation	MT
Apr. 17	ReNeuron CFO steps down to pursue other opportunities	AN

RENEURON ISSUES ADMINISTRATION WARNING	Feb. 06	AQ
Edison issues update on ReNeuron Group (RENE): H124 results reaffirm focus on CustomEX™	Nov. 27	EQ
ReNeuron : Interim Statement 2023	Nov. 16	PU
ReNeuron : Presentation	Nov. 07	PU
ReNeuron : 24 July 2023 – Notice of Annual General Meeting	23-07-24	PU
ReNeuron : Annual Report 2023	23-06-16	PU
ReNeuron has extended cash runway as it focuses on validating its exosome platform	23-02-21	AQ
ReNeuron : Preliminary results presentation for the year ended 31 March 2022	22-07-06	PU
ReNeuron : Preliminary Results for the year ended 31 March 2022	22-07-04	PU
ReNeuron : Update on the Technology Transfer and Supply Agreement with Fosun Pharma	22-07-01	PU
ReNeuron : Interim Statement 2021	21-12-07	PU
ReNeuron : New CTX-iPSC platform data shows potential in Peripheral Nerve Repair	21-11-19	PU
ReNeuron : Collaboration agreement with UCL	21-10-26	PU
ReNeuron : First subject treated at Oxford Eye Hospital in Phase 2a RP trial	21-10-18	PU
ReNeuron : Further changes in the Board of Directors	21-10-18	PU
ReNeuron : First subject treated at Oxford Eye Hospital	21-10-18	PU
ReNeuron : Regulatory approval for continuation of Phase 2a RP trial	21-10-01	PU
ReNeuron : Annual Report 2021	21-08-10	PU
ReNeuron : Preliminary results presentation for the year ended 31 March 2021	21-07-09	PU
ReNeuron : Preliminary Results for the year ended 31 March 2021	21-07-08	PU

No results for this search